Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy

OBJECTIVE: We hypothesized that intranasal insulin (I-I) delivery targets the nervous system while avoiding potential adverse systemic effects when compared with subcutaneous insulin (S-I) for experimental streptozotocin-induced diabetic peripheral neuropathy (DPN). RESEARCH DESIGN AND METHODS: I-I...

Descripción completa

Detalles Bibliográficos
Autores principales: Francis, George, Martinez, Jose, Liu, Wei, Nguyen, Thuhien, Ayer, Amit, Fine, Jared, Zochodne, Douglas, Hanson, Leah R., Frey, William H., Toth, Cory
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661595/
https://www.ncbi.nlm.nih.gov/pubmed/19136650
http://dx.doi.org/10.2337/db08-1287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661595/
https://www.ncbi.nlm.nih.gov/pubmed/19136650
http://dx.doi.org/10.2337/db08-1287

Ejemplares similares